Cite
HARVARD Citation
Okuno, M. et al. (2020). Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K‐RAS status for unresectable colorectal liver metastasis (BECK study): Long‐term results of survival. Journal of hepato-biliary-pancreatic sciences. pp. 496-509. [Online].